Vitamin E Reduces Monocyte Tissue Factor Expression in Cirrhotic Patients
Authors:
Open Access
- 1 May 1999
- journal article
- Published by American Society of Hematology in Blood
- Vol. 93 (9) , 2945-2950
Abstract
Clotting activation may occur in liver cirrhosis, but the pathophysiological mechanism has not been fully elucidated. Because a previous study demonstrated that lipid peroxidation is increased in cirrhosis, we analyzed whether there is a relationship between lipid peroxidation and clotting activation. Thirty cirrhotic patients (19 men and 11 women; age, 34 to 79 years) and 30 controls matched for sex and age were investigated. In all subjects, monocyte expression of tissue factor (TF) antigen and activity; plasma levels of prothrombin fragment 1+2 (F1+2), a marker of thrombin generation; and urinary excretion of Isoprostane-F2-III, a marker of lipid peroxidation, were measured. Furthermore, the above-reported variables were re-evaluated after 30 days of treatment with standard therapy (n = 5) or standard therapy plus 300 mg vitamin E twice daily (n = 9). In addition, we analyzed in vitro if vitamin E (50 μmol/L) influenced monocyte TF expression and F1+2 generation. Cirrhotic patients had higher values of Isoprostane-F2-III (P < .0001), F1+2 (P < .0001), and monocyte TF antigen (P < .0001) and activity (P < .03) than controls. Isoprostane-F2-III was significantly correlated with F1+2 (Rho = 0.85; P < .0001) and TF antigen (Rho = 0.95; P < .0001) and activity (Rho = 0.94;P < .0001). After vitamin E treatment, Isoprostane-F2-III (P = .008), F1+2 (P < .008), and monocyte TF antigen (P = .012) and activity (P = .008) significantly decreased; no changes of these variables were detected in patients not receiving vitamin E. In vitro, vitamin E significantly reduced the expression of monocyte TF antigen (−52%; P = .001) and activity (−55%; P= .003), as well as F1+2 generation (−51%; P = .025). This study shows that vitamin E reduces both lipid peroxidation and clotting activation and suggests that lipid peroxidation may be an important mediator of clotting activation in liver cirrhosis.Keywords
This publication has 26 references indexed in Scilit:
- Enhanced expression of monocyte tissue factor in patients with liver cirrhosisGut, 1998
- 8-Epi PGF2αGeneration During Coronary ReperfusionCirculation, 1997
- Modulation of Oxidant Stress In Vivo in Chronic Cigarette SmokersCirculation, 1996
- Association between low-grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosisGastroenterology, 1995
- LPS directly induces oxygen radical production in human monocytes via LPS binding protein and CD14Journal of Leukocyte Biology, 1995
- Free radicals and phagocytic cellsThe FASEB Journal, 1995
- Monocyte tissue factor induction by lipopolysaccharide (LPS): dependence on LPS-binding protein and CD14, and inhibition by a recombinant fragment of bactericidal/permeability-increasing proteinBlood, 1994
- Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.Journal of Clinical Investigation, 1994
- Hyperfibrinolysis Increases the Risk of Gastrointestinal Hemorrhage in Patients With Advanced CirrhosisHepatology, 1992
- Hemostasis and Fibrinolysis in Severe Liver Failure and Their Relation to HemorrhageHepatology, 1986